Two Sigma Advisers’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-475,470
Closed -$38.1M 2578
2016
Q4
$38.1M Sell
475,470
-331,662
-41% -$26.3M 0.15% 166
2016
Q3
$64.4M Sell
807,132
-258,396
-24% -$20.9M 0.27% 88
2016
Q2
$83.1M Buy
1,065,528
+145,900
+16% +$10.4M 0.42% 53
2016
Q1
$50.6M Buy
919,628
+307,299
+50% +$16.7M 0.28% 92
2015
Q4
$37.8M Buy
612,329
+569,878
+1,342% +$35.9M 0.23% 122
2015
Q3
$2.68M Sell
42,451
-585,466
-93% -$41.8M 0.02% 655
2015
Q2
$45.9M Sell
627,917
-84,845
-12% -$6.13M 0.34% 71
2015
Q1
$46.6M Buy
712,762
+15,700
+2% +$1.04M 0.34% 75
2014
Q4
$45.3M Buy
697,062
+7,900
+1% +$509K 0.35% 59
2014
Q3
$41.4M Buy
689,162
+151,800
+28% +$9.92M 0.31% 78
2014
Q2
$37.2M Buy
537,362
+373,200
+227% +$24.2M 0.29% 75
2014
Q1
$10.7M Buy
+164,162
New +$10.7M 0.1% 226

Other funds holding STJ

Two Sigma Advisers's STJ Position: Q1 2017 in Review

Two Sigma Advisers sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 475,470 shares — an estimated $38.1M sold.

Two Sigma Advisers first reported a position in STJ in Q1 2014 and held it in 12 quarters. The position peaked at $83.1M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Two Sigma Advisers reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Two Sigma Advisers sold 475,470 St Jude Medical shares in Q1 2017, an estimated $38.1M.
  • Two Sigma Advisers first reported a position in St Jude Medical in Q1 2014 and held it in 12 quarters.
  • Two Sigma Advisers's St Jude Medical position peaked at $83.1M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Two Sigma Advisers's 13F filing for Q1 2017, filed 15 May 2017.